|Articles|October 28, 2016
KMR Group Conducts Annual Cycle Time Report
KMR Group recently conducted its annual Clinical Trial Cycle Time Report.
Advertisement
KMR Group recently conducted its annual Clinical Trial Cycle Time Report. Results of the analysis show the duration of clinical trials associated with large molecule drugs take significantly longer than trials associated with small molecule drugs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
Using AI and Tokenized Data to Match Patients to Protocols
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
